Furthermore, research conducted within the CASABLANCA cohort demonstrated that OPN, in conjunction with CysC, markedly enhanced the prediction of CI-AKI and long-term negative outcomes, including nonprocedural AKI, CKD progression, myocardial infarction, and all-cause mortality [138,139]. Here, SPP1 is linked to chronic kidney disease.